CIK 0001712762
- Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465211056
- Phone
- +1 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- Open-market buys, last 90 days
- $1,039,671
- in 1 filing
- Open-market sales, last 90 days
- $1,175,048
- in 1 filing
Net −$135,378. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-10 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Grant or award | +8,641 | 54,765 | ||
| 2024-04-04 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Exercise or conversion | +64,848 | $1.16 | $75K | 75,155 |
| 2024-04-04 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Shares withheld for taxes | −29,031 | $2.58 | $75K | 46,124 |
| 2024-04-04 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Exercise or conversion · Stock Option (right to buy) | −64,848 | 0 | ||
| 2024-01-31 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Grant or award | +6,688 | 10,307 | ||
| 2022-11-17 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Grant or award | +3,619 | 3,619 |
Page 1 of 1 · 6 trades